What is Sanara MedTech Inc.'s SG&A?

Sanara MedTech Inc. (SMTI) reported SG&A of $21.88M in Q1 2026.

How has Sanara MedTech Inc.'s SG&A changed year-over-year?

Sanara MedTech Inc.'s SG&A increased by 14.4% year-over-year, from $19.13M to $21.88M.

What is the long-term trend for Sanara MedTech Inc.'s SG&A?

Over 4 years (2021 to 2025), Sanara MedTech Inc.'s SG&A has grown at a 30.2% compound annual growth rate (CAGR), from $28.05M to $80.64M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Sanara MedTech Inc. SMTI SG&A

SG&A at other companies

Becton, Dickinson and CompanyBDX

$1.21B+8.6%

StrykerSYK

$2.28B-0.8%

IAR

Integra LifeSciencesIART

$178.24M-1.8%

SolventumSOLV

$827M+7.5%

Orthofix Medical Inc.OFIX

$134.91M+1.5%

ClearPoint NeuroCLPT

$5M+22.4%

Other financials

Income statement

See full

Revenue$27.8M+18.6%

Gross profit$25.9M+19.8%

Operating income$2.6M+221%

Net income$459.0K+113%

EPS (diluted)$0.05+112%

Balance sheet

See full

Cash & equivalents$13.6M-34.3%

Total debt$48.4M+8.2%

Total equity$7.0M-80.8%

Total assets$69.3M-28.1%

Cash flow

See full

Operating cash flow-$2.5M-23.3%

CapEx$43.8K-97.5%

Free cash flow-$2.5M+32.6%

Valuation

See full

Market cap$216.18M-9.7%

Enterprise value$250.95M-6.5%

P/S2×-0.5×

Profitability

See full

Gross margin92.9%+1.8pp

Operating margin6.1%+5.1pp

Net margin-31.2%-93.4pp

FCF margin-9.8%-3.5pp

Returns & leverage

See full

Return on equity-153.7%-199pp

Debt / equity6.9×+5.7×

Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sanara MedTech Inc.'s SG&A?: Sanara MedTech Inc. (SMTI) reported SG&A of $21.88M in Q1 2026.
How has Sanara MedTech Inc.'s SG&A changed year-over-year?: Sanara MedTech Inc.'s SG&A increased by 14.4% year-over-year, from $19.13M to $21.88M.
What is the long-term trend for Sanara MedTech Inc.'s SG&A?: Over 4 years (2021 to 2025), Sanara MedTech Inc.'s SG&A has grown at a 30.2% compound annual growth rate (CAGR), from $28.05M to $80.64M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.